Mahabadi AA, et al. - Whether lipoprotein(a) (Lp[a]) distinguishes patients ≥70 years with and without aortic valve stenosis (AVS), was determined by examining patients ≥70 years with AVS, scheduled for transcatheter aortic valve implantation, matched with patients without AVS by age-group and gender. In both groups, Lp(a) levels were compared and stratified by presence and absence of clinical coronary artery disease (CAD) manifestation. In this large cohort, Lp(a) was found to be related to clinical CAD manifesation, no association with AVS was seen. There was no impact of Lp(a) on the development of AVS in patients over 70 years.